<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

    <MetaVariables>
        <Submitter/>
        <Method/>
    </MetaVariables>
    <MetaLinks/>

    <Projects>
        <Project/>
    </Projects>

    <Studies>

        <Study source="dbGaP" accession="phs000997.v4.p2" parentStudy="phs000997.v4.p2" createDate="2020-01-16"
               modDate="2020-02-11">

            <Configuration>
                <Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>M. Benjamin Shoemaker, MD</td><td>Vanderbilt University, Nashville, TN,USA</td></tr>
		<tr><td>Funding Source</td><td>1K23HL127704</td><td>National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA</td></tr>
		<tr><td>Funding Source</td><td>AHA 11CRP7420009</td><td>American Heart Association, Dallas, TX, USA</td></tr>
		</table>
	]]></Data_Provider>
                <StudyNameEntrez>NHLBI TOPMed - NHGRI CCDG: The Vanderbilt AF Ablation Registry</StudyNameEntrez>
                <StudyNameReportPage>NHLBI TOPMed - NHGRI CCDG: The Vanderbilt AF Ablation Registry
                </StudyNameReportPage>
                <StudyTypes>
                    <StudyType>Case Set</StudyType>
                </StudyTypes>
                <Description><![CDATA[
<p>The Vanderbilt Atrial Fibrillation Ablation Registry (VAFAR) was founded in 2011. Patients with AF referred for AF ablation are prospectively enrolled. A detailed clinical history is recorded, along with imaging data (cardiac MRI or CT). Blood samples are obtained for DNA extraction at the time of ablation. Details of the ablation procedure are recorded. Patients are longitudinally followed to monitor for AF recurrence. VAFAR contributed 171 samples submitted to dbGaP for WGS: 115 were from male subjects, of which 113 were white/non-Hispanic and 2 were Hispanic; 56 were from females, of which all 56 were white/non-Hispanic.</p>]]>
                </Description>
                <StudyInEx><![CDATA[
<p>Patients with AF referred for AF ablation are included.</p>]]>
                </StudyInEx>
                <StudyProjects>
                    <Project/>
                </StudyProjects>
                <Publications>
                    <Publication>
                        <Pubmed pmid="25684755"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="23876437"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="23428961"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="23168290"/>
                    </Publication>
                    <Publication>
                        <Pubmed pmid="25876528"/>
                    </Publication>
                </Publications>
                <Diseases>
                    <Disease vocab_source="MESH" vocab_term="Atrial Fibrillation"/>
                </Diseases>
                <Attributions>
                    <Header title="Principal Investigator">
                        <AttName>M. Benjamin Shoemaker, MD</AttName>
                        <Institution>Vanderbilt University, Nashville, TN,USA</Institution>
                    </Header>
                    <Header title="Funding Source">
                        <AttName>1K23HL127704</AttName>
                        <Institution>National Heart Lung and Blood Institute, National Institutes of Health, Bethesda,
                            MD, USA
                        </Institution>
                    </Header>
                    <Header title="Funding Source">
                        <AttName>AHA 11CRP7420009</AttName>
                        <Institution>American Heart Association, Dallas, TX, USA</Institution>
                    </Header>
                </Attributions>
                <DisplayPublicSummary>yes</DisplayPublicSummary>
                <ConsentGroups>
                    <ConsentGroup groupNum="1" shortName="HMB-IRB" longName="Health/Medical/Biomedical (IRB)"/>
                </ConsentGroups>
            </Configuration>

            <AuthorizedAccess>
                <DacInfo ssDacId="0">
                    <DacName>NHLBI</DacName>
                    <DacFullName>National Heart, Lung, and Blood Institute DAC</DacFullName>
                    <DacEmail>0</DacEmail>
                    <DacPhone/>
                    <DacUrl/>
                </DacInfo>
                <Policy Policy_ID="phs000997.v4.p2_policy" ref_ssDacId="0">
                    <DisplayResearchStatement>yes</DisplayResearchStatement>
                    <DisplayPublicSummary>yes</DisplayPublicSummary>
                    <EmbargoLength>0</EmbargoLength>
                    <YearsUntilRenewal>1</YearsUntilRenewal>
                    <WeeksCancelRequest>8</WeeksCancelRequest>
                    <PdfSupplementReqired>yes</PdfSupplementReqired>
                    <AcknowledgementText>
                        <para>
                            http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000997.v4.p2
                        </para>
                    </AcknowledgementText>
                    <DocumentSet>
                        <DataUseCertificate Label="Data Use Certificate"
                                            FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000997.v4.p2"
                                            FileName=""/>
                    </DocumentSet>
                </Policy>
                <ConsentGroups>
                    <ParticipantSet groupNum-REF="1">
                        <ConsentName>Health/Medical/Biomedical (IRB)</ConsentName>
                        <ConsentAbbrev>HMB-IRB</ConsentAbbrev>
                        <UseLimitation>Use of this data is limited to health/medical/biomedical purposes, does not
                            include the study of population origins or ancestry.
                            Requestor must provide documentation of local IRB approval.
                        </UseLimitation>
                        <IrbRequired>Yes</IrbRequired>
                    </ParticipantSet>
                </ConsentGroups>
            </AuthorizedAccess>
            <Documents>
                <Document phd="phd007493.2" type="protocol" createDate="2018-07-06" modDate="2020-02-10"
                          urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd007493.2"
                          urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000997.v4.p2&amp;phd=7493">
                    <OrigName>WGS Methods Freeze5b_180705.docx</OrigName>
                    <DisplayName>TOPMed Whole Genome Sequencing Project - Freeze 5b, Phases 1 and 2</DisplayName>
                    <Description>TOPMed Whole Genome Sequencing Project - Freeze 5b, Phases 1 and 2</Description>
                    <displayStatus>public</displayStatus>
                    <xmlStatus>public</xmlStatus>
                </Document>
                <Document phd="phd008024.1" type="protocol" createDate="2019-09-25" modDate="2020-02-11"
                          urlToXml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/GetDocumentXml.cgi?document_id=phd008024.1"
                          urlToHtml="http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/document.cgi?study_id=phs000997.v4.p2&amp;phd=8024">
                    <OrigName>TOPMed_WGS_Methods_Freeze8.docx</OrigName>
                    <DisplayName>TOPMed Whole Genome Sequencing Methods: Freeze 8</DisplayName>
                    <Description>TOPMed Whole Genome Sequencing Methods: Freeze 8</Description>
                    <displayStatus>public</displayStatus>
                    <xmlStatus>public</xmlStatus>
                </Document>
            </Documents>


        </Study>

    </Studies>

</GaPExchange>
